Name: Heidelberg Pharma AG - BioCentury Company Profiles - BCIQ
Creator: Biocentury

signInButton

SIGN IN

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Please note, you are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. Request a trial to unlock the full value of BCIQ.

REQUEST A FREE TRIAL

AcquiredOrMerged

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.

If you believe a company has been archived in error, please contact us at 

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.\nIf you believe a company has been archived in error, please contact us at \nsupport@biocentury.com\n.

Cat-H(AcquiredorMerged)

Historical deals and financings can be found by searching the organization's name in the BCIQ <DEALS> and <FINANCING> Modules.

Default (Company Type Blank)

CategoryHDefault (Company Type Blank)

NonBioPharma

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.

Cat-H(NonBioPharma)

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.\n

Heidelberg Pharma AG

Cambrian explosion of ADCs at AACR24

June 29 Quick Takes: Disclosure of impropriety jeopardizes integrity of BioXcel’s trial

Clinical BCMA antibody therapies behind Tecvayli

Feb. 28 Quick Takes: Heidelberg shares jump as Huadong takes stake

Feb. 18 Quick Takes: $200M to ease Synthego into gene, cell therapy

Trastuzumab-RNA polymerase inhibitor conjugate for breast cancer with low HER2 expression

Cancer

Cancer

Telix raises A$50M in Australian IPO

Telix raises A$50M in Australian IPO